These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1361829

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study.
    Honkanen E, Kala AR, Grönhagen-Riska C, Ikäheimo R.
    Adv Perit Dial; 1992; 8():356-61. PubMed ID: 1361822
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Calcium mass transfer in peritoneal dialysis patients using 2.5 mEq/l calcium dialysate.
    Piraino B, Bernardini J, Holley J, Johnston JR, Perlmutter JA, Martis L.
    Clin Nephrol; 1992 Jan; 37(1):48-51. PubMed ID: 1541065
    [Abstract] [Full Text] [Related]

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Satisfactory control of secondary hyperparathyroidism with low-calcium dialysate in patients not receiving vitamin D.
    Teruel JL, Nitvarro JF, Marcen R, Aguilera A, Tato A, Ottuño J.
    Miner Electrolyte Metab; 1997 Nov; 23(1):19-24. PubMed ID: 9058365
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients.
    Hwang JC, Chen CA, Wang CT, Chen HC.
    Ren Fail; 2008 Nov; 30(10):943-51. PubMed ID: 19016144
    [Abstract] [Full Text] [Related]

  • 14. [Chronic kidney disease (CKD) and bone. Management of chronic kidney disease-mineral and bone disorder in peritoneal dialysis patients].
    Yaginuma T, Yamamoto H.
    Clin Calcium; 2009 Apr; 19(4):508-13. PubMed ID: 19329829
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.
    Spasovski G, Gelev S, Masin-Spasovska J, Selim G, Sikole A, Vanholder R.
    Bone; 2007 Oct; 41(4):698-703. PubMed ID: 17643363
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
    Weinreich T, Passlick-Deetjen J, Ritz E.
    Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.